Eagle Pharmaceuticals, Inc. (EGRX)
NASDAQ: EGRX · IEX Real-Time Price · USD
4.760
+0.010 (0.21%)
May 17, 2024, 4:00 PM EDT - Market closed

Eagle Pharmaceuticals Revenue

Eagle Pharmaceuticals had revenue of $257.55M in the twelve months ending June 30, 2023, down -5.38% year-over-year. Revenue in the quarter ending June 30, 2023 was $64.65M, a -12.80% decrease year-over-year. In the year 2022, Eagle Pharmaceuticals had annual revenue of $316.61M with 84.56% growth.

Revenue (ttm)
$257.55M
Revenue Growth
-5.38%
P/S Ratio
0.24
Revenue / Employee
$1,922,022
Employees
134
Market Cap
61.82M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022316.61M145.06M84.56%
Dec 31, 2021171.55M-16.26M-8.66%
Dec 31, 2020187.80M-8.09M-4.13%
Dec 31, 2019195.89M-17.42M-8.17%
Dec 31, 2018213.31M-23.40M-9.88%
Dec 31, 2017236.71M47.23M24.92%
Dec 31, 2016189.48M123.26M186.11%
Dec 31, 201566.23M47.13M246.76%
Sep 30, 201419.10M5.42M39.62%
Sep 30, 201313.68M11.14M438.76%
Sep 30, 20122.54M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

EGRX News

More News